BMLBMLKF 69 Interest Coverage is 40.71 as of Mar. 2026, which is 84% below its 10-year median of 248.17. GuruFocus rates BMLKF with a GF Score™ of 69/100 and a GF Value™ of $26.78. The stock has 2 warning signs investors should review. Among 95 Medical Diagnostics & Research companies, BML ranks better than 85.26% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. BML's
Operating Income
for the
three
months ended in Mar. 2026 was $7.7 Mil. BML's Interest Expense for the
three
months ended in Mar. 2026 was $-0.2 Mil.
BML's interest coverage for the quarter that ended in Mar. 2026 was 40.71.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. BML Inc has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for BML's Interest Coverage or its related term are showing as below:
BMLKF'
s Interest Coverage Range Over the Past 10 Years
Min: 79.36 Med: 248.17 Max: 1358.06
Current: 87.58
BMLKF's Interest Coverage is ranked better than 85.26% of 95
companies
in the Medical Diagnostics & Research industry
Industry Median: 9.05
vs BMLKF: 87.58
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
BML Interest Coverage Related Terms
BML Interest Coverage Historical Data
* Premium members only.
The historical data trend for BML's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BMLKF vs TMO, DHR, IDXX: Interest Coverage Comparison
For the Diagnostics & Research subindustry, BML's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BML Interest Coverage vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, BML's Interest Coverage distribution charts can be found below:
* The bar in red indicates where BML's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BML (BMLKF) has a Interest Coverage of 40.71 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on BML and its competitors. This is 84% below median its historical median of 248.17. Over the past decade, BML's Interest Coverage has ranged from 79.36 to 1,358.06. According to the industry distribution chart, BML ranks #14 out of 95 companies in the Medical Diagnostics & Research industry, placing it in the top 14.7%.
Is BML's Interest Coverage too high?
BML's current Interest Coverage of 40.71 is 84% below median its 10-year median of 248.17. Over the past 10 years, this metric has ranged from a low of 79.36 to a high of 1,358.06. The Medical Diagnostics & Research industry median Interest Coverage is 9.05. BML's value of 40.71 is 349.8% above this industry median. Based on the distribution chart, BML ranks #14 out of 95 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, BML has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does BML's Interest Coverage compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, BML ranks #14 out of 95 companies for Interest Coverage. This places BML in the top 15% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 9.05. BML's value of 40.71 is 349.8% above this benchmark. Historically, BML's own Interest Coverage has ranged from 79.36 to 1,358.06 over the past decade. While the company's 10-year median is 248.17 vs. the industry median of 9.05, BML has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Diagnostics & Research company?
The median Interest Coverage among Medical Diagnostics & Research companies is 9.05, based on 95 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BML's current Interest Coverage of 40.71 is 349.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on BML and its competitors. For the Medical Diagnostics & Research industry, the median Interest Coverage is 9.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BML's current Interest Coverage is 40.71, which is 84% below median its own 10-year median of 248.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BML stock overvalued right now?
BML (BMLKF) has a current Interest Coverage of 40.71. The stock's GF Value™ is $26.78, compared to a current price of $25.21 — trading 5.9% below its estimated fair value. The current Interest Coverage is 40.71, which is 84% below median its 10-year median of 248.17 and 349.8% above the Medical Diagnostics & Research industry median of 9.05. BML's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For BML (BMLKF), the current Interest Coverage is 40.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BML (BMLKF) Overvalued in 2026?
Based on GuruFocus' analysis, BML stock appears to be undervalued.
The current stock price of $25.21 is trading 5.9% below its estimated GF Value™ of $26.78.
Key valuation signals for BMLKF:
Interest Coverage: 40.71 (84% below median its 10-year median of 248.17)
GF Value™: $26.78 vs. price of $25.21 (5.9% below fair value)
Industry Position: 349.8% above the Medical Diagnostics & Research median (#14 of 95)
No single metric tells the full story. See the BMLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.
69GF Score
Get the complete analysis for BMLKF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BMLKF has been successfully added to your 
